Results 221 to 230 of about 22,458 (270)
Some of the next articles are maybe not open access.

Antiemetics revisited

Current Opinion in Oncology, 1997
In the past few years a combination of a 5-HT3 receptor antagonist plus dexamethasone has been shown to be the most efficacious antiemetic prophylaxis of acute emesis induced by cisplatin and moderately emetogenic chemotherapy. In the prevention of cisplatin-induced delayed emesis oral metoclopramide or ondansetron, both combined with dexamethasone ...
F, Roila, A, Del Favero
openaire   +2 more sources

Antiemetic therapy

Critical Reviews in Oncology/Hematology, 2002
The emetogenic potential of cancer chemotherapeutic agents varies according to the agent employed. Among the highly emetogenic agents, cisplatin has been the most studied. As for emesis induced by cisplatin, an optimal antiemetic schedule is effective in 70-90% of cases of acute emesis, in 60% of cases of delayed emesis, whereas acute emesis induced by
L. Licitra, S. Spinazzé, F. Roila
openaire   +3 more sources

Corticosteroids as Antiemetics

1988
Although several antiemetic agents can exert some control of cancer chemotherapy-related nausea and vomiting, none is totally effective. As in many other instances of medical treatment, combinations of drugs will probably prove the best means of controlling the situation.
openaire   +2 more sources

Antiemetics

Reactions Weekly, 2021
openaire   +2 more sources

Antiemetics

Drugs, 1983
John Laszlo   +3 more
openaire   +1 more source

Antiemetic treatment

European Journal of Cancer and Clinical Oncology, 1985
openaire   +2 more sources

Antiemetics

Reactions Weekly, 2006
openaire   +2 more sources

Antiemetics

2015
Wendy A. Haft, Richard McAffee
openaire   +1 more source

Home - About - Disclaimer - Privacy